Showing results (1271-1280 of 1,390) with videos related to
Sort By:
Pageof 139
Journal of Medicinal Chemistry|February 27, 2018
Design and Synthesis of Novel Deuterated Ligands Functionally Selective for the γ-Aminobutyric Acid Type A Receptor (GABA<sub>A</sub>R) α6 Subtype with Improved Metabolic Stability and Enhanced BioavailabilityDaniel E Knutson, Revathi Kodali, Branka Divović, et al.American Journal of Human Genetics|April 7, 2023
Evidence of epistasis in regions of long-range linkage disequilibrium across five complex diseases in the UK Biobank and eMERGE datasetsPankhuri Singhal, Yogasudha Veturi, Scott M Dudek, et al.Diabetes|February 22, 2022
Endothelial Phospholipase Cγ2 Improves Outcomes of Diabetic Ischemic Limb Rescue Following VEGF TherapyYashika Rustagi, Ahmed S Abouhashem, Priyanka Verma, et al.Cancers|September 5, 2020
Critical Role for Cold Shock Protein YB-1 in CytokinesisSunali Mehta, Michael Algie, Tariq Al-Jabry, et al.Plos Genetics|June 4, 2021
Novel EDGE encoding method enhances ability to identify genetic interactionsMolly A Hall, John Wallace, Anastasia M Lucas, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 26, 2025
Tissue nanotransfection-based endothelial PLCγ2-targeted epigenetic gene editing rescues perfusion and diabetic ischemic wound healingSumit S Verma, Chandan K Sen, Rajneesh Srivastava, et al.ESMO Open|May 25, 2024
Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer patients with brain metastases from the randomized DESTINY-Breast03 trialS A Hurvitz, S-B Kim, W-P Chung, et al.Biodata Mining|December 18, 2015
Identifying gene-gene interactions that are highly associated with Body Mass Index using Quantitative Multifactor Dimensionality Reduction (QMDR)Rishika De, Shefali S Verma, Fotios Drenos, et al.Journal of Personalized Medicine|December 23, 2022
The Penn Medicine BioBank: Towards a Genomics-Enabled Learning Healthcare System to Accelerate Precision Medicine in a Diverse PopulationAnurag Verma, Scott M Damrauer, Nawar Naseer, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 3, 2018
Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancerG N Hortobagyi, S M Stemmer, H A Burris, et al.Pageof 139